Delivery of siRNA using novel conjugates for cancer therapy.
Short interfering RNAs (siRNAs) trigger RNA interference (RNAi). This offers great potential as a novel therapeutic treatment based on its highly specific silencing of the encoded protein. A major barrier to the advancement of siRNA therapies is the development of delivery carriers capable of effect...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project (FYP) |
| Language: | English |
| Published: |
2010
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/40472 |